September 15, 2014 9:17 PM ET

Biotechnology

Company Overview of Nymirum, Inc.

Company Overview

Nymirum, Inc., a drug discovery company, develops drug discovery platforms that target RNA with small molecules. It offers a platform that provides new molecules and scaffolds for newly validated RNA targets, which are fed into the traditional med chem and biology pipeline. The company’s drug discovery platform is an approach that identifies specific atomic-level RNA conformers which co-exist in a dynamic ensemble. Nymirum, Inc. was incorporated in 2009 and is based in Ann Arbor, Michigan.

3510 West Liberty Road

Ann Arbor, MI 48103

United States

Founded in 2009

Phone:

734-369-4268

Key Executives for Nymirum, Inc.

Chief Executive Officer
Co-Founder and President
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Cognetix, Inc. United States
AveXis, Inc. United States
Acureon Pharmaceuticals, Inc. United States
Xylos Corporation United States
Aveva Drug Delivery Systems, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Nymirum, Inc., please visit nymirum.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.